Nanoviricides Inc (NYSEMKT:NNVC) Sentiment Change Report at 2

“Big money” Positions

“Big money sentiment for Nanoviricides Inc (NYSEMKT:NNVC) in 2018 Q2 increased to 2, according to SEC filings. That’s up 1.00, from 2018Q1’s 1. 12 active investment managers increased or started new positions, while 6 sold and reduced their stakes in Nanoviricides Inc so the sentiment improved. These funds own 3.64 million shares, that’s up from 3.49 million shares in 2018Q1. Funds holding Nanoviricides Inc in top 10 was flat from 0 to 0 for the same number . In total 2 funds closed positions, 4 reduced and 7 increased. Also 5 funds bought new Nanoviricides Inc stakes.

Most Nanoviricides Inc Investors

As of 2018 Q2 Pioneer Trust Bank N A Or has 0.02% invested in Nanoviricides Inc. Nanoviricides Inc’s shareholder Wharton Business Group Llc owns 363,513 shares as of 2018 Q2. Bank Of America Corp De reported 15,817 shares. The New York-based fund Bank Of New York Mellon Corp have invested about 0% of the active investment manager’s stock portfolio in Nanoviricides Inc. The Ohio-based fund Bartlett & Co. Llc looks positive on Nanoviricides Inc, owning 40,714 shares.

NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections.The firm is valued at $25.50 million. The firm is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus drug candidate that could enable a functional cure for HIV/AIDS.Currently it has negative earnings. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; anti-viral eye drops against external eye viral infections; and other research programs against Rabies virus, Ebola, and Marburg viruses.

The stock increased 5.00% or $0.0175 during the last trading session, reaching $0.3675.Currently NanoViricides, Inc. is downtrending after 72.63% change in last December 8, 2017. NNVC has 37,778 shares volume. The stock underperformed the S&P 500 by 88.25%.

Sequoia Fin Advsr Limited Liability Company has invested 0% in NanoViricides, Inc. (NYSEAMERICAN:NNVC). State Bank Of America De reported 15,817 shs. The New York-based Morgan Stanley has invested 0% in NanoViricides, Inc. (NYSEAMERICAN:NNVC). Geode Cap Management Ltd Co holds 0% of its capital in NanoViricides, Inc. (NYSEAMERICAN:NNVC) for 175,983 shs. Wells Fargo & Co Mn has 1,059 shs for 0% of their capital. Virtu Fincl Limited Liability Co reported 0% of its capital in NanoViricides, Inc. (NYSEAMERICAN:NNVC). 100,000 were reported by Pioneer Tru Bancorporation N A Or. Citadel Advisors Ltd Co invested 0% of its capital in NanoViricides, Inc. (NYSEAMERICAN:NNVC). Deutsche Bankshares Ag reported 0% stake. Sandy Spring National Bank invested in 4,154 shs. Moreover, Renaissance Ltd Limited Liability Company has 0% invested in NanoViricides, Inc. (NYSEAMERICAN:NNVC). Savings Bank Of New York Mellon stated it has 0% of its capital in NanoViricides, Inc. (NYSEAMERICAN:NNVC). 60,572 were accumulated by Raymond James And Assocs. Scotia Cap accumulated 19,384 shs or 0% of the stock. Bartlett Co Limited Liability Company, a Ohio-based fund reported 40,714 shs.

For more NanoViricides, Inc. (NYSEAMERICAN:NNVC) news brought out recently go to: Twst.com, Twst.com, Twst.com, Twst.com or Twst.com. The titles are as follows: “Protalix BioTherapeutics Inc.: Protalix BioTherapeutics Reports 2018 Third Quarter Results and Provides Corporate Update – The Wall Street Transcript” brought out on November 07, 2018, “NovaBay Pharmaceuticals Inc.: NovaBay Pharmaceuticals to Hold Third Quarter 2018 Conference Call on November 14, 2018 – The Wall Street Transcript” on November 14, 2018, “CVS Health Corporation: CVS Health Reports Third Quarter Results – The Wall Street Transcript” with a publish date: November 06, 2018, “ACCO Brands Corporation: ACCO Brands Corporation Reports Third Quarter 2018 Results – The Wall Street Transcript” and the last “Contango Oil and Gas Co.: Contango Announces Schedule for Third Quarter Earnings and Operations Release – The Wall Street Transcript” with publication date: November 02, 2018.

NanoViricides, Inc. (NYSEAMERICAN:NNVC) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.